Creativity is key to drug R&D

In a world where time to market is money, the pharmaceutical industry faces special challenges. To improve their candidate drugs' odds and decrease development time and costs, pharmaceutical companies have started to form numerous alliances with public and private institutions and launch major research and development initiatives. The author considers how scientific and computational advances have created unprecedented opportunities for innovation.